Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ANI Pharma Inc
(NQ:
ANIP
)
63.52
+0.27 (+0.43%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ANI Pharma Inc
< Previous
1
2
3
4
5
Next >
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team
February 24, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders
January 24, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
January 05, 2022
Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference
January 03, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
December 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...
Via
Benzinga
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
December 21, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
December 20, 2021
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
7 of the Best Small-Cap Stocks to Buy Before 2022
December 16, 2021
With 2021 coming to a close and a new year upon us, it's time to get a head start on some of the best small-cap stocks to buy.
Via
InvestorPlace
This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position
December 13, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
November 22, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021
November 22, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Receives Clearance from U.S. Federal Trade Commission for the Acquisition of Novitium Pharma
November 11, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock
November 08, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock
November 03, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
November 03, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript
November 01, 2021
ANIP earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
November 01, 2021
ANI Pharmaceuticals Inc (NASDAQ: ANIP) has reported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of $49.70 million. The company achieved an...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Product Safety
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
November 01, 2021
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow, SPX Fall From Record Intraday Highs
November 01, 2021
Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
November 01, 2021
The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.
Via
The Motley Fool
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Product Safety
Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump
November 01, 2021
Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug
November 01, 2021
Cortophin Gel gained approval to treat several autoimmune conditions.
Via
Investor's Business Daily
Exposures
Product Safety
40 Stocks Moving In Monday's Mid-Day Session
November 01, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the...
Via
Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
November 01, 2021
According to Benzinga Pro data, during Q3, ANI Pharmaceuticals (NASDAQ:ANIP) posted sales of $52.06 million. Earnings were up 77.1%, but ANI Pharmaceuticals still reported an...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views
November 01, 2021
Following the market opening Monday, the Dow traded up 0.08% to 35,846.72 while the NASDAQ rose 0.18% to 15,527.04. The S&P also fell, dropping 0.07% to 4,602.32. The U.S. has...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.